Emerging insights into the structure and function of complement C5a receptors
Complement factor C5a is an integral constituent of the complement cascade critically
involved in the innate immune response, and it exerts its functions via two distinct receptors …
involved in the innate immune response, and it exerts its functions via two distinct receptors …
Cutting edge: GPR35/CXCR8 is the receptor of the mucosal chemokine CXCL17
JL Maravillas-Montero, AM Burkhardt… - The Journal of …, 2015 - journals.aai.org
Chemokines are chemotactic cytokines that direct the traffic of leukocytes and other cells in
the body. Chemokines bind to G protein–coupled receptors expressed on target cells to …
the body. Chemokines bind to G protein–coupled receptors expressed on target cells to …
CCL13 and human diseases
L Li, F Dai, L Wang, Y Sun, L Mei, Y Ran… - Frontiers in …, 2023 - frontiersin.org
CCL13/MCP-4 belongs to the CC chemokine family, which induces chemotaxis in many
immune cells. Despite extensive research into its function in numerous disorders, a thorough …
immune cells. Despite extensive research into its function in numerous disorders, a thorough …
Chemokine regulation of neutrophil infiltration of skin wounds
Y Su, A Richmond - Advances in wound care, 2015 - liebertpub.com
Significance: Efficient recruitment of neutrophils to an injured skin lesion is an important
innate immune response for wound repair. Defects in neutrophil recruitment lead to impaired …
innate immune response for wound repair. Defects in neutrophil recruitment lead to impaired …
Molecular basis for CCRL2 regulation of leukocyte migration
T Schioppa, F Sozio, I Barbazza, S Scutera… - Frontiers in cell and …, 2020 - frontiersin.org
CCRL2 is a seven-transmembrane domain receptor that belongs to the chemokine receptor
family. At difference from other members of this family, CCRL2 does not promote chemotaxis …
family. At difference from other members of this family, CCRL2 does not promote chemotaxis …
Multifaceted roles of chemokines and chemokine receptors in tumor immunity
K Matsuo, O Yoshie, T Nakayama - Cancers, 2021 - mdpi.com
Simple Summary Various immune cells are involved in host immune responses to cancer. T-
helper (Th) 1 cells, cytotoxic CD8+ T cells, and natural killer cells are the major effector cells …
helper (Th) 1 cells, cytotoxic CD8+ T cells, and natural killer cells are the major effector cells …
Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligation
Background Natural killer (NK) cells have a unique capability of spontaneous cytotoxicity
against malignant cells and hold promise for off-the-shelf cell therapy against cancer. One of …
against malignant cells and hold promise for off-the-shelf cell therapy against cancer. One of …
Monocyte chemoattractant protein-1 (MCP-1/CCL2) in diabetic retinopathy: latest evidence and clinical considerations
Y Taghavi, G Hassanshahi, NG Kounis, I Koniari… - Journal of cell …, 2019 - Springer
Diabetic retinopathy (DR) is considered as a diabetes-related complication that can render
severe visual impairments and is also a risk factor for acquired blindness in both developed …
severe visual impairments and is also a risk factor for acquired blindness in both developed …
Interstitial-resident memory CD8+ T cells sustain frontline epithelial memory in the lung
S Takamura, S Kato, C Motozono, T Shimaoka… - Journal of Experimental …, 2019 - rupress.org
Populations of CD8+ lung-resident memory T (TRM) cells persist in the interstitium and
epithelium (airways) following recovery from respiratory virus infections. While it is clear that …
epithelium (airways) following recovery from respiratory virus infections. While it is clear that …
Leukocyte trafficking in tumor microenvironment
Highlights•Chemotactic factors released in tumor microenvironment shape leukocyte
recruitment.•Tumor infiltrate can drive both pro-and anti-tumor activities.•Tumor infiltrating …
recruitment.•Tumor infiltrate can drive both pro-and anti-tumor activities.•Tumor infiltrating …